Biotechnology companies from Sweden seek partners in the US
Sweden leads the world in per-capita concentration of biotech companies. The Stockholm / Uppsala region, which continually places at the top of international rankings is responsible in great part for this statistic. During BIO2003, companies in the region will be seeking new partnerships.
Sweden leads the world in per-capita concentration of biotech companies. The Stockholm / Uppsala region, which continually places at the top of international rankings is responsible in great part for this statistic. During BIO2003, companies in the region will be seeking new partnerships.
Sweden has the greatest number of biotechnology companies, per capita, in the world, and fifty percent of them are in the Stockholm/Uppsala bioregion. It is home to more than 550 life sciences companies, about 100 businesses in the biotechnological field, and an additional 100 enterprises that are biotech-related.
'The majority are smaller, newly established companies with cutting-edge expertise, and they're generating big investment possibilities,' says Per-Axel Dahlberg, interim ceo of Business Arena Stockholm.
The region's companies represent all aspects of the value chain: r&d, manufacture, and commercialisation. Companies that develop and manufacture instruments and equipment and deal with documentation and registration are also represented.
Among other qualities that distinguish the Stockholm/Uppsala bioregion is the climate for clinical trials. Many people are willing to act as test subjects, and the patient database is unique for its size and content. The Svenska laekemedelsverket [Medical Products Agency (MPA)] is one of the world's most respected regulatory agencies and is recognized globally for its professional attitude and quick, sound decisions.
International comparisons show that the Swedish research climate yields results. Per capita, Sweden has more patents registered in the United States than any country in Europe. It holds more EU patents per capita than any other country in the world. The number of published scientific articles per capita puts Sweden at second place in international rankings.
During BIO2003, the world's biggest biotechnology fair, to be held in Washington, DC, June 21-25, the region's companies will be looking for new collaborative partners.